Issue of Convertible Bonds with Share (OCA) for a maximum nominal amount of 3.5 millions euros over 3 years.

Both companies are finalizing the contribution agreement and the exchange parity.

Worldwide launching of the latest version of Myrian^® during the Chinese hospital information systems tradeshow.

This 5-year agreement guarantees Intrasense recurring revenues with this new partner.

Intrasense and DMS Group enter exclusive negotiations for the contribution of DMS Group medical imaging activities to Intrasense.

Intrasense announces its 2017 financial results and strategy for 2018.

Intrasense introduces Myrian^® new features and proves its seamless integration capabilities within any health information system.

Partners announce after HIMSS exhibition a multi-year partnership contract, for the creation of an innovative product based on Myrian® technologies.

The Hypmed project, in which Intrasense is a partner, will be presented at European Congress of Radiology in Vienna.

Intrasense announces the appointment of a new management team, with a new Chairman and new Chief Executive Officer.